Search Results - "Elgengehy, Fatema"

Role of miR-146a rs2910164 and UTS2 rs228648 Genetic Variants in Behçet's Disease by Kamal, Asmaa, Elgengehy, Fatema T, Elawady, Zahraa, Fawzy, Nahla A., El Sisi, Ola

“…Behçet's disease (BD) is a chronic autoimmune inflammatory disease. Clinical studies revealed that both microRNAs and urotensin II (UTS2) play a significant…”
Get full text

Therapeutic antioxidant and anti-inflammatory effects of laser acupuncture on patients with rheumatoid arthritis by Attia, Atef M. M., Ibrahim, Fatma A. A., Abd El-Latif, Noha A., Aziz, Samir W., Elwan, Azhar M., Abdel Aziz, Abdel Aziz A., Elgendy, Aliaa, Elgengehy, Fatema T.

“…Background and Objective The laser acupuncture has many potential therapeutic effects. Currently, they are not evaluated for their therapeutic effects on…”
Get full text

Comorbidities among Egyptian systemic lupus erythematosus: The COMOSLE-EGYPT study by Gamal, Sherif M, Mokbel, Abir, Niazy, Marwa H., Elgengehy, Fatema T, Elsaid, Nora Y, Fouad, Nermeen A., Sobhy, Nesreen, Tantawy, Marwa, Mohamed, Sally S., Ghaleb, Rasha M, Abdelaleem, Enas A, El-Zorkany, Bassel

“…Objective To study the prevalence and impact of comorbidities among a cohort of patients with systemic lupus erythematosus (SLE). Methods This study is…”
Get full text

The role of microRNA-31 and microRNA-21 as regulatory biomarkers in the activation of T lymphocytes of Egyptian lupus patients by Amr, Khalda Sayed, Bayoumi, Faten S., Elgengehy, Fatema T., Abdallah, Sanaa O., Ahmed, Hanan H., Eissa, Eman

“…Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by familial aggregation and genetic predisposition. MicroRNAs (MiRNAs) serve as…”
Get full text

Analysis of Nuclear Receptor Coactivator 5 (NCOA5) Messenger RNA Expression and rs2903908 Single Nucleotide Polymorphism of NCOA5 in an Egyptian Cohort with Behçet's Disease: A Single-Center Case-control Study by Koptan, Dina M.T., Rasheed Bahgat, Dina M., Abdelrasool, Asmaa A., Allam, Riham S.H.M., Elgengehy, Fatema T, Abdel Baki, Noha M, Medhat, Basma M

“…The nuclear receptor coactivator 5 (NCOA5) has been linked to several inflammatory disorders, including Behçet's disease (BD). We evaluated the expression of…”
Get full text

The association of TRAP1 gene and TNFSF4 gene polymorphisms with susceptibility of rheumatoid arthritis in a sample of Egyptian patients by Ibrahim, Alshaymaa, Abdelhadi, Maha, Ashmawy, Ingy, Ramadan, Abeer, Wahby, Aliaa, Hassan, Mirhane, Elgengehy, Fatema, Baki, Noha Abdel

“…Background/aim The disclosure of new gene polymorphisms and their association with rheumatoid arthritis (RA) susceptibility open new windows for better…”
Get full text

Vasculitis damage index in Behçet's disease by Elgengehy, Fatema T, Gamal, Sherif M, Sobhy, Nesreen, Siam, Ibrahem, Soliman, Ahmed M, Elhady, Ghada W, Gheita, Tamer A

“…Vasculitis damage index (VDI) is a validated damage index for systemic vasculitis, and as Behçet's disease is considered one of systemic vascular disease we…”
Get full text

Association of VDR ApaI and TaqI Gene Polymorphisms with the Risk of Scleroderma and Behçet's Disease by Kamal, Asmaa, Gamal, Sherif M., Elgengehy, Fatema T., Alkemary, Alkhateeb K., Siam, Ibrahem

“…Vitamin D deficiency and vitamin D receptor (VDR) gene polymorphisms have been reported in autoimmune diseases. However, their role in Behçet's disease (BD)…”
Get full text

Growth Differentiation Factor-15 (GDF-15) Level and Relation to Clinical Manifestations in Egyptian Systemic Sclerosis patients: Preliminary Data by Gamal, Sherif M., Elgengehy, Fatema T., Kamal, Asmaa, El Bakry, Samah A., Shabaan, Elham, Elgendy, Aliaa, Bassyouni, Iman H.

“…Aim of the work: This study aims to assess Growth differentiation factor-15 (GDF-15) level in Scleroderma patients and its relation to disease manifestations…”
Get full text

Matrix Metalloproteinase-9 rs17576 Gene Polymorphism and Behçet's Disease: Is There an Association? by Kamal, Asmaa, Elgengehy, Fatema T., Abd Elaziz, Mohamed Momtaz, Gamal, Sherif M., Sobhy, Nesreen, Medhat, Amira, El Dakrony, Al Hussein M.

“…Background: Clinical studies have reported a significant association between matrix metalloproteinases (MMP), particularly (MMP-9), and inflammatory diseases…”
Get full text

Choroidal Thickness and microRNA146 in Lupus Nephritis Patients by Hassan Salah, Shaymaa, Makled, Hebatalla Samir, ElMekawey, Hany, Elgengehy, Fatema T, Medhat, Basma M, Abdel Baki, Noha M, Koptan, Dina

“…To evaluate the choroidal thickness (CT) in the macular area in patients with lupus nephritis and to compare the results with both non-nephritic patients and…”
Get full text

Milk fat globule E-8 and interleukin 17 in systemic lupus erythematosus: partners in crime? by Madkour, Lamiaa, Elgengehy, Fatema, Niazy, Marwa, Ghoneim, Shada

“…Systemic lupus erythematosus (SLE) is a multi-factorial, autoimmune disease with a wide array of manifestations. The pro-inflammatory cytokine interleukin…”
Get full text

Association of interleukin-6 and its -174G/C promoter polymorphism with clinical and laboratory characteristics of non hepatitis C virus rheumatoid arthritis patients by Raafat Hamed, Reham Mohamed, Mohamed, Soliman Aref, Dwedar, Reham Ali, Elkholy, Yasmine Samy, Elgengehy, Fatema Talaat

“…Interleukin-6 is a cytokine protein, which causes inflammation, maintains immune homeostasis and shows a role in rheumatoid arthritis pathogenesis. IL-6-174G/C…”
Get full text

Study of urotensin-2 (T21M and S89N) gene polymorphisms in systemic sclerosis by Kamal, Asmaa, Elgengehy, Fatema T, EL Dakrony, AL Hussein M.

“…Systemic sclerosis (SSc) is an immune-mediated fibrotic disease. Urotensin II (UTS2) is a new peptide with vasoactive and fibrogenic features, an association…”
Get full text

Thrombocytopenia and disease outcomes in a cohort of patients with systemic lupus erythematosus. A post hoc analysis of the COMOSLE‐EGYPT study by Mohamed, Sally Samy, Gamal, Sherif Mohamed, Mokbel, Abir, Alkamary, Alkhateeb Kadery, Siam, Ibrahem, Soliman, Ahmed, Elgengehy, Fatema Talaat

“…Background Thrombocytopenia ranges from 20% to 40% in patients with systemic lupus erythematosus (SLE). It is usually associated with severe disease…”
Get full text

Mortality in a cohort of Egyptian systemic lupus erythematosus patients: A comparison with African, Arabic, and Mediterranean studies by Gamal, Sherif, Rady, Hanaa, Sobhy, Nesreen, Siam, Ibrahem, Soliman, Ahmed, Elgengehy, Fatema

“…Objectives: The study aimed to examine the frequency, causes, and predictors of mortality in a cohort of Egyptian systemic lupus erythematosus (SLE) patients…”
Get full text

Plasma circPTPN22 and its potential target microRNA-200a-3p as novel diagnostic biomarkers in systemic lupus erythematosus patients by Mowafy, Hagar L., Kotb, Maha M., Hanna, Kamal M., Elgengehy, Fatema T., Madkour, Lamiaa A.

“…Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with heterogeneous manifestations and intricate pathophysiology. Driven by its complicated…”
Get full text

HLA Class I in Egyptian patients with Behçet's disease: new association with susceptibility, protection, presentation and severity of manifestations by Elfishawi, Mohanad M., Elgengehy, Fatema, Mossallam, Ghada, Elfishawi, Sally, Alfishawy, Mostafa, Gad, Abdallah, Mokhtar, Imman

“…Introduction: Behçet's disease is an autoimmune disease with diverse clinical manifestations with vasculitis being the hallmark of the disease. The aim of this…”
Get full text

Galectin-3 and interleukin-7 as potential serologic markers in rheumatoid arthritis patients by Abdel Baki, Noha M., Elgengehy, Fatema T., Zahran, Abeer M., Ghoniem, Shada, Elsayed, Eman, Medhat, Amira, Ali, Hany F., Elashmawy, Hossam

“…To assess the level of serum galectin-3 and interleukin-7 (Il-7) in rheumatoid arthritis (RA) patients and to study their association with disease activity as…”
Get full text

Choroidal Thickness and microRNAI46 in Lupus Nephritis Patients by Salah, Shaymaa Hassan, Makled, Hebatalla Samir, ElMekawey, Hany, Elgengehy, Fatema T, Medhat, Basma M, Baki, Noha M. Abdel, Koptan, Dina

“…Purpose: To evaluate the choroidal thickness (CT) in the macular area in patients with lupus nephritis and to compare the results with both non-nephritic…”
Get full text